Catalyst4 is a nonprofit investment vehicle established by Google co-founder Sergey Brin, funded by roughly $366 million from the sale of his Tesla stake, with a mission to support breakthroughs in central-nervous-system and neurological disorders and in mitigating climate change. In the psychedelic sector it committed about $15 million of a $25 million round into Soneira, a biotech advancing synthetic ibogaine for traumatic brain injury.
Investor Context
Venture CapitalInvestment Context
This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage focus is not listed yet. Psychedelic-market posture: Psychedelic-Adjacent Focus.
Public Portfolio Examples
- SoneiraVenture financing round - $25 million funding round - Jul 1, 2024
Catalyst4 is Sergey Brin's family-office vehicle; recorded here for its documented financing of Soneira's psychedelic mental-health programme. Profile details beyond documented deals are unverified.
Investor Type
Venture Capital Fund
Geographic Scope
Global
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement
Active
Investment Stage Focus
Stage focus is not listed yet.
Investment Focus Areas
Focus areas are not listed yet.
Recorded Investments
Jul 1, 2024
Venture financing round - $25 million funding round
Sergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments